Compumedics

Compumedics Depreciation & Amortization

Depreciation & Amortization of Compumedics (CMP.AX) as of Nov 22, 2026.

Depreciation & Amortization

0.00AUD

Last updated:

Depreciation & Amortization of Compumedics is 2026 0.00 AUD. Depreciation & Amortization of Compumedics was 2025 0.00 AUD. It decreases by % lower compared to the previous year.

The Compumedics Depreciation & Amortization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Depreciation & Amortization
Date
Depreciation & Amortization
Jan 1, 2019
0.00 AUD
Jan 1, 2020
0.00 AUD
Jan 1, 2021
0.00 AUD
Jan 1, 2022
0.00 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026
0.00 AUD
The Compumedics Depreciation & Amortization history
YEARDepreciation & AmortizationYoY
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD-100.00%
17.00 MAUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Compumedics Stock analysis

What does Compumedics do? Compumedics Ltd. generates revenue through the sale of medical equipment including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, and ultrasonic blood-flow systems. The company's product portfolio features Somfit/Somfit Pro, Grael 4K PSG:EEG, Grael PSG, Somte PSG, Somte, Okti, and Siesta 802, which are distributed across geographic segments Americas, Australia, Asia Pacific, and Europe and the Middle East. CMP's neurology laboratory solutions support clinical epilepsy monitoring, electromyography diagnostics, and transcranial doppler sonography. Compumedics Neuroscan brand offers brain research technologies for electroencephalogram, ERPs, source localization, and functional neuro-imaging. The company serves healthcare providers and medical facilities requiring diagnostic and monitoring equipment. Its products target neurology, sleep medicine, and clinical research applications. CMP's solutions are marketed under the Compumedics Neuroscan brand for brain research technologies. The geographic segments drive sales with specific product offerings tailored to regional healthcare needs. Compumedics Neuroscan technologies provide electroencephalogram and functional neuro-imaging solutions for research and clinical use. The company's product range includes diagnostic systems for sleep disorders, epilepsy monitoring, and blood-flow analysis. CMP's technical service and support services complement the hardware sales, ensuring customer satisfaction and repeat business. Sales are conducted through direct channels within the Americas, Australia, Asia Pacific, and Europe and the Middle East segments. Compumedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compumedics stock

On Eulerpool you can find the complete historical development of Depreciation & Amortization Compumedics since 2006 – with annual values, charts, and detailed analysis.

Depreciation & Amortization represents the allocation of the cost of tangible and intangible assets over their useful lives.

Depreciation & Amortization's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Depreciation & Amortization's Compumedics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Compumedics

All Key Metrics — Compumedics